首页> 外文期刊>Endocrine >The effects of angiotensin peptides and angiotensin receptor antagonists on the cell growth and angiogenic activity of GH3 lactosomatotroph cells in vitro
【24h】

The effects of angiotensin peptides and angiotensin receptor antagonists on the cell growth and angiogenic activity of GH3 lactosomatotroph cells in vitro

机译:血管紧张素肽和血管紧张素受体拮抗剂对GH3泌乳体营养细胞体外生长和血管生成活性的影响

获取原文
获取原文并翻译 | 示例
       

摘要

The local renin–angiotensin system (RAS) is present in the pituitary gland, and inhibitory effects of angiotensins on the lactosomatotroph (GH3) cell growth have been revealed. The aim of this study was to examine the influence of various angiotensin peptides and angiotensin AT1, AT2, and AT4 receptors antagonists on the cell proliferation, viability, and VEGF secretion in pituitary lactosomatotroph GH3 cell culture in order to identify receptors involved in antiproliferative effects of angiotensins on GH3 tumor cells. Cell viability and proliferation using Mosmann method and BrdU incorporation during DNA synthesis, and VEGF secretion using ELISA assay were estimated. The inhibitory effects of ang II, ang IV, and ang 5–8 on the cell viability and BrdU incorporation in GH3 culture were not abolished by AT1, AT2, and AT4 receptors antagonists. Ang II, as well as ang III and ang IV at lower concentrations stimulated the secretion of VEGF in GH3 cell culture. The secretion of VEGF was inhibited by ang III and ang IV at higher concentrations. AT1 and AT2 receptors antagonists prevented the proangiogenic effects of ang II. Ang II, ang IV, and ang 5–8 decrease the cell number and proliferation in GH3 cell culture independently of the AT1, AT2, and AT4 receptors. These peptides affect also secretion of VEGF in culture examined. Both the AT1 and AT2 receptors appear to mediate the proangiogenic effects of ang II.
机译:垂体腺中存在局部的肾素-血管紧张素系统(RAS),并且已经揭示了血管紧张素对乳突营养(GH3)细胞生长的抑制作用。这项研究的目的是检查各种血管紧张素肽和血管紧张素AT1,AT2和AT4受体拮抗剂对垂体泌乳激素营养生长激素GH3细胞培养物中细胞增殖,生存能力和VEGF分泌的影响,以鉴定参与抗垂体泌尿激素营养不良的受体。 GH3肿瘤细胞上的血管紧张素。在DNA合成过程中使用Mosmann方法和BrdU掺入来评估细胞活力和增殖,并使用ELISA法评估细胞的VEGF分泌。 AT1,AT2和AT4受体拮抗剂并未消除ang II,ang IV和Ang 5-8对GH3培养物中细胞活力和BrdU掺入的抑制作用。较低浓度的Ang II以及Ang III和Ang IV刺激GH3细胞培养物中VEGF的分泌。较高浓度的血管紧张素Ⅲ和血管紧张素Ⅳ抑制VEGF的分泌。 AT1和AT2受体拮抗剂可预防ang II的促血管生成作用。 Ang II,Ang IV和Ang 5-8可以独立于AT1,AT2和AT4受体而减少GH3细胞培养物中的细胞数量和增殖。这些肽还影响所检查培养物中VEGF的分泌。 AT1和AT2受体似乎都介导ang II的促血管生成作用。

著录项

  • 来源
    《Endocrine》 |2012年第1期|p.88-96|共9页
  • 作者单位

    Department of Endocrinology, The County Hospital of Kutno, 52 Kosciuszki Street, 99-300, Kutno, Poland;

    Clinic of Endocrinology, Medical University of Lodz, Dr Sterling 3 Street, 91-425, Lodz, Poland;

    Department of Immunoendocrinology, Medical University of Lodz, Dr Sterling 3 Street, 91-425, Lodz, Poland;

    Department of Immunoendocrinology, Medical University of Lodz, Dr Sterling 3 Street, 91-425, Lodz, Poland;

    Clinic of Endocrinology, Medical University of Lodz, Dr Sterling 3 Street, 91-425, Lodz, Poland;

    Department of Immunoendocrinology, Medical University of Lodz, Dr Sterling 3 Street, 91-425, Lodz, Poland;

    Department of Immunoendocrinology, Medical University of Lodz, Dr Sterling 3 Street, 91-425, Lodz, Poland;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Pituitary tumor; GH3 cell line; Angiotensin; Angiotensin receptor antagonist; Cell proliferation; VEGF;

    机译:垂体瘤;GH3细胞系;血管紧张素;血管紧张素受体拮抗剂;细胞增殖;VEGF;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号